Recap: Rite Aid Q1 Earnings

 

Shares of Rite Aid RAD moved higher by 2.4% in pre-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share were up 1050.00% over the past year to $0.38, which beat the estimate of $0.22.

Revenue of $6,161,000,000 rose by 2.22% year over year, which missed the estimate of $6,210,000,000.

Guidance

Rite Aid said it sees FY22 sales of $25.1 billion-$25.5 billion and adjusted EPS of $(0.79)-$(0.24).

Details Of The Call

Date: Jun 24, 2021

Time: 12:00 PM

ET Webcast URL: https://investors.riteaid.com/events-and-presentations/event-details/2021/Rite-Aids-FY22-First-Quarter-Earnings/default.aspx

Recent Stock Performance

52-week high: $32.48

Company's 52-week low was at $8.86

Price action over last quarter: Up 18.48%

Company Description

Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!